CIDeRplusGeneral Information:
| Id: | 6,438 (click here to show other Interactions for entry) |
| Diseases: |
Diabetes mellitus, type I
- [OMIM]
Diabetes mellitus, type II - [OMIM] Insulin resistance |
| Rattus norvegicus | |
| male | |
| streptozotocin-induced diabetic rat | |
| article | |
| Reference: | Bahmani F et al.(2012) Glycine therapy inhibits the progression of cataract in streptozotocin-induced diabetic rats Mol. Vis. 18: 439-448 [PMID: 22355255] |
Interaction Information:
| Comment | The purpose of this paper was to investigate the effect of the oral administration of L-glycine (Gly) on the development of diabetic cataract induced by streptozotocin (STZ) in rats. Diabetic cataract gradually progressed in the STZ-administered group with no other treatment. Consequently, up to the end of the experiment, 2/3 of the animals in this group reached to the last stage of the cataract (mature cataract). The progress of this process was much slower in the diabetic group that was treated with Gly. |
|
Formal Description Interaction-ID: 60779 |
|
| Drugbank entries | Show/Hide entries for Glycine |